Jane Trepel, n/a

National Cancer Institute
Bethesda, Maryland, United States

Presentation(s):

• Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS

  Thursday, November 17, 2022
  1:40 PM – 1:48 PM